| Document |
Document Title |
|
JP2022530784A |
The present invention relates to a method for producing urea, in which a) methyl formate or ammonium formate is formed as an intermediate in a catalytic reaction to prepare formamide based on carbon dioxide, hydrogen and ammonia, and b) ...
|
|
JP2022530783A |
The present invention relates to the use of a ruthenium-phosphine complex as a catalyst for catalytic synthesis of urea, which comprises the conversion of formamide or formamide with ammonia in the presence of a catalyst, thereby forming...
|
|
JP7092356B2 |
The present invention discloses a biaryl urea ROR³t inhibitor, and specifically relates to a biaryl urea derivative, as represented by formula I, with an ROR³t inhibiting activity, and a preparation process thereof, and a pharmaceutica...
|
|
JP7088770B2 |
There is provided a process and an apparatus for urea production in which preheating of raw material ammonia or heating in a medium-pressure decomposition step can be performed at a relatively low pressure while preventing decrease in an...
|
|
JP2022528950A |
The present invention relates to a novel compound having anticancer activity and a method for producing the same, and more particularly to a novel compound which suppresses the expression of AIMP2-DX2 and exhibits excellent anticancer ac...
|
|
JP7085020B2 |
The invention relates to a urea production plant at least comprisinga. a synthesis and recovery section (1);b. a first evaporation section (2) connected with the synthesis and recovery section (1) and a first condensation section (6);c. ...
|
|
JP2022527294A |
The present disclosure relates to therapeutic methods or agents in inflammatory diseases and specific neuropathy associated with inflammatory signaling processes including, but not limited to, compounds, pharmaceutical compositions conta...
|
|
JP7075928B2 |
The present invention discloses a nicotinyl alcohol ether derivative, a preparation method therefor, and a pharmaceutical composition and uses thereof. Specifically, the invention relates to nicotinyl alcohol ether derivatives represente...
|
|
JP7066117B2 |
There is provided a novel gelator containing a monourea derivative. A gelator comprising a compound of formula (1): wherein R 1 is a linear or branched alkyl group having a carbon atom number of 2 to 20, a cyclic alkyl group having a car...
|
|
JP2022069882A |
To provide a novel compound that is improved in solubility in organic solvents and can capture anions.The compound is represented by the general formula (1) in the figure. (In the formula, R1 and R2 each independently represent H, an alk...
|
|
JP2022525186A |
The compounds of the present disclosure, as well as their compositions and methods of use. The compound inhibits the activity of the TEAD transcription factor and is useful in the treatment of diseases associated with the activity of the...
|
|
JP7054096B2 |
The objective of the present invention is to provide a method for producing a fluorinated carbonate derivative in a safe and efficient manner. The method for producing a fluorinated carbonate derivative according to the present invention...
|
|
JP2022053981A |
To readily produce a filter with a small fiber diameter without using a nonwoven fabric filter.A self-assembly agent is to form a nanofiber network structure by self-assembly. The self-assembly agent contains a compound represented by ge...
|
|
JP2022520907A |
In particular, the Nurr1 receptor regulator and its use are described herein. In one aspect, a method is provided for treating a disease associated with dysregulation and / or degeneration of dopaminergic neurons in the central nervous s...
|
|
JP2022050538A |
To provide modulators of the prostacyclin (PGI2) receptor useful for treatment of disorders related to the PGI2 receptor.Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in treatme...
|
|
JP7041925B2 |
The objective of the present invention is to provide a method for producing a carbonate derivative in a safe and efficient manner. The method for producing a carbonate derivative according to the present invention is characterized in com...
|
|
JP7038223B2 |
Provided is a photosensitive resin composition having excellent curability and storage stability. Also, provided are: a cured film employing the photosensitive resin composition; a layered product; a production method for a cured film; a...
|
|
JP7028780B2 |
The present invention relates to a benzamide derivative of general formula I, a drug composition containing same and a use thereof as a drug, wherein the definitions of R 1 , Z and Q are as described in the description.
|
|
JP6998733B2 |
To provide a thermal recording material which has good color developing sensitivity and excellent heat resistance of a surface.A thermal recording material contains at least one compound represented by a formula (1) in the figure as a de...
|
|
JP2022024484A |
To provide a nanostructure having an excellent TOF (turnover frequency) when used as an OER (oxygen evolution reaction) catalyst.A nanostructure includes: a sheet-like main layer having an approximately conical hollow shape and laminated...
|
|
JP7004641B2 |
The invention relates to the use of thermoplastic molding masses to produce molded bodies of any type having improved optical properties, said molding masses containing A) 30 to 99.99 wt% of a thermoplastic polyamide, B) 0.01 to 10 wt% o...
|
|
JP2022509385A |
The present invention44Sc,47Sc,55Co,62Cu,64Cu,67Cu,66Ga,67Ga,68Ga,89Zr,8
6Y,90Y,90Nb,99mTc,111ln,135Sm,140Pr,159Gd,149Tb,160Tb,161Tb,
165Er,166Dy,166Ho,175Yb,177Lu,186Re,188Re,213Bi and225Ac, or18F,131I or211A chelating agent or fluorina...
|
|
JP2022506755A |
The present invention is acceptable for aspartic acid derivatives having the structure represented by the formula (I) in the preparation of animal feed additives or racemates, stereoisomers, geometric isomers, tautomers, solvates or feed...
|
|
JP2022501412A |
The present disclosure discloses ionizable amine lipids and salts thereof (eg, pharmaceutically acceptable thereof) useful for delivery of bioactive agents, eg, delivery of bioactive agents to cells for preparing engineered cells. Salt) ...
|
|
JP2021195347A |
To provide a polyisocyanate composition excellent in storage stability, and capable of suppressing coloring of a modified body, and to provide a modified body composition obtained by modifying the polyisocyanate composition.In a polyisoc...
|
|
JP2021536492A |
The present invention provides illudin derivatives, intermediates, methods of preparation, pharmaceutical compositions, and their use. Specific examples include novel synthetic pathways for preparing illudin derivatives and illudin deriv...
|
|
JP6986564B2 |
Provided are: a curing agent for magnetic recording media, which contains a compound represented by general formula (1); a composition for magnetic recording media, which contains this curing agent for magnetic recording media; a method ...
|
|
JP6983234B2 |
An integrated process for production of urea and urea-ammonium sulphate (“UAS”) comprises: a urea synthesis step carried out in a urea synthesis reactor; a recovery and concentration step, wherein a urea solution produced in the urea...
|
|
JP2021191732A |
To provide a method of producing valuables from exhaust from cement production, allowing effective use of CO2 in exhaust from cement production equipment not originating from fossil fuel, for reducing CO2 originating from energy.CO2 in e...
|
|
JP2021191734A |
To provide a method for producing a urea derivative from carbamate as the raw material.A method for producing a urea derivative includes a reaction step in which, in the presence of a catalyst, carbamate is heated, to produce a urea deri...
|
|
JP6976953B2 |
The present invention provides compounds of Formula (I):or stereoisomers, tautomers, or pharmaceutically-acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This inven...
|
|
JP6974120B2 |
The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, wherein U, J, V, X, R 2a , R 2b , R 2c , R 5 and t are as described herein. The present invention rel...
|
|
JP2021178821A |
To provide compounds that modulate FPR biological activity.The present disclosure relates to phenyl urea derivatives, methods for preparing them, pharmaceutical compositions containing them, and their use as pharmaceuticals as modulators...
|
|
JP6948313B6 |
The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions fu...
|
|
JP6960532B2 |
The present invention provides a method for producing an amino acid aminoalkyl ester or an inorganic acid salt thereof by reacting a compound represented by general formula (I) shown below or a compound represented by general formula (II...
|
|
JP6960468B2 |
The present invention is provided with a reformer 1 for reforming a hydrocarbon source to obtain hydrogen and carbon dioxide, an ammonia production unit 10 for using the hydrogen and carbon dioxide obtained by the reformer 1 to obtain am...
|
|
JP2021529814A |
The present invention is directed to substituted carbon-bonded bicycloalkane derivatives. Specifically, the present invention targets compounds according to formula (X) or salts thereof, including pharmaceutically acceptable salts thereo...
|
|
JP6949693B2 |
Disclosed are: a treatment method comprising (1) a step in which an aqueous solution containing urea, ammonia and carbon dioxide is introduced into a first stripper (PCS1) and subjected to stripping, and the aqueous solution after stripp...
|
|
JP6946577B2 |
The present invention relates to the technical field of natural substance extraction. Disclosed is a method for extracting Citrulline from a watermelon. The method for extracting Citrulline from a watermelon in the present invention comp...
|
|
JP6944465B2 |
The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs) for use in treating or reducin...
|
|
JP6943239B2 |
An object of the present invention is to provide a novel compound having a strong opening action with respect to KCNQ2-5 channels. A compound represented by the general formula (I) (wherein the definition of each group is as described in...
|
|
JP2021525810A |
Compound of tryptophan catabolism modulator formula (I): [Chemical 1]And associated with abnormal or elevated catalytic effects of tryptophan, such as cancer, immunosuppression, viral infection, depression, neurodegenerative disorders, t...
|
|
JP2021123686A |
To provide: a co-crosslinking agent exhibiting good elongation properties and tear strength; a thermal crosslinking resin composition containing the same; and a molding obtained therefrom.A co-crosslinking agent contains an allylurea com...
|
|
JP6923537B2 |
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, compositions containing suc...
|
|
JP2021113157A |
To provide a novel method for producing alkyl urea compounds.A method for producing an alkyl urea compound of general formula (2), includes mixing and heating an alkyl amine compound of general formula (1) and carbon dioxide in the prese...
|
|
JP2021518836A |
The present invention relates to substituted alkynylene compounds represented by compounds of formula (I), pharmaceutically acceptable salts thereof and stereoisomers thereof. The present invention further provides a method for preparing...
|
|
JP6869344B2 |
An object of the present invention is to provide a recording material or a recording sheet using, as a color-developing agent, a non-phenol-based compound good in color developing performance and the like. A compound represented by the f...
|
|
JP6850911B2 |
The present invention relates to a vinylarene deriv. which modulates or inhibits the enzymic activity of indoleamine 2,3-dioxygenase 1 (IDO-1), and the use thereof, and further relates to a vinylarene deriv. and the use thereof. The viny...
|
|
JP6852347B2 |
The present invention provides a liquid crystal aligning agent, a liquid crystal alignment film, a liquid crystal element, a polymer, and a diamine, thereby obtaining a liquid crystal cell having excellent AC residual image characteristi...
|
|
JP6851869B2 |
When recovering and utilizing the urea and NH3contained in a gas that contains urea dust and NH3and has been discharged from a urea granulation step, an aqueous urea solution to be fed to the urea granulation step is prevented from suffe...
|
